InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,320.65
(
-0.01%
)
US TECH 100
18,270.00
(
0.21%
)
Dow Jones
39,839.33
(
-0.08%
)
Brent Oil
82.28
(
-0.21%
)
Bitcoin
70,087.64
(
-0.09%
)
Post# of 14684
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Solar_Express

Send PM Follow Ignore
Followers 73
Posts 10908
Boards Moderated 1
Alias Born 10/02/2009

Solar_Express

Re: docj post# 11944

Saturday, 04/18/2020 2:51:31 PM

Saturday, April 18, 2020 2:51:31 PM

Post# of 14684
Generex Biotechnology Provides Update on the Development of an Ii-Key- SARS-CoV-2 Peptide Vaccine Against the COVID-19 Pandemic

Working with a team of corporate collaborators, academic advisors, and contract manufacturers to prepare contract proposals and bids for U.S. and international government health agencies to develop Ii-Key-SARS-CoV-2 peptide vaccines against COVID-19 for clinical testing and approval

http://www.globenewswire.com/news-release/2020/04/14/2015691/0/en/Generex-Biotechnology-Provides-Update-on-the-Development-of-an-Ii-Key-SARS-CoV-2-Peptide-Vaccine-Against-the-COVID-19-Pandemic.html

In the I-Box
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up